APP and early-onset autosomal dominant Alzheimer disease: With subsequent streptavidin pull-down and LCMS analysis, they identified several dozen membrane proteins whose shedding in the extracellular space depended on the activity of BACE1 (beta-secretase), a proteolytic enzyme mediating the liberation of amyloid precursor protein from neurons, and a key drug target for Alzheimer’s disease.